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Accepted 11 March 2010Congenital cytomegalovirus (CMV) infection is symp-
tomatic in approximately 10% of infected neonates and is
associated with clinically significant brain damage and
sensorineural hearing loss in almost one-half of those infected
[1e3]. In addition, neurologic defects will eventually develop
in 8e13% of neonates with asymptomatic infections. The
prenatal diagnosis of congenital infection is possible; however,
there has been much debate about the value of screening for
fetal CMV infections. Although CMV-specific hyper-
immunoglobulin therapy is possible for the prevention and
treatment against fetal CMV infections, no prenatal therapy or
vaccine is currently available. There is no accurate means to
predict the sequelae of primary infections. Up to 2% of all
infants excrete CMV, and attempts to identify and isolate the
viral agent are expensive and impractical. Serologic screening
is not recommended by the American College of Obstetricians
and Gynecologists [4]. Screening for prenatal CMV infection
is not mandatory in Taiwan but is performed at the physician’s
discretion and with the patient’s consent. Therefore, the
prenatal suspicion and diagnosis of CMV is an enormous
clinical challenge for obstetricians.
Primary maternal CMV infection during pregnancy leads to
vertical transmission in around 30e50% of fetuses, and the
rate of transmission (0.2e1%) is far lower for mothers with
secondary infection relatively [5e7]. Only 10e15% of
newborns of mothers with primary CMV infection during
pregnancy present the typical clinical findings of congenital
CMV [8e10]. Although the fetuses can be infected by CMV
throughout the whole pregnancy and several studies have
suggested that gestational age at infection has no apparent
influence on the rate of transmission [11,12], an increased risk* Corresponding author. Department of Obstetrics and Gynecology, Chang
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[13] and Daiminger et al [14]. Furthermore, a greater risk of
symptomatic fetal involvement was noted in infections
occurring during the first half of the pregnancy or near the
time of conception, whereas infections in the second half
result in less sequelae [7,11]. The fetal damage is also more
severe in early primary infection than in late infection [7,9].
Although all of the factors influencing the severity of CMV
infection are not known, maternal and fetal immune status and
viral strain virulence are considered to play a significant role
[15]. When CMV affects a twin gestation, both of the twins
usually have clinical or laboratory evidence of infection. The
data in the literature pertaining to congenital CMV infection in
twins, however, are limited [16e21]. Twin gestations represent
an interesting model for CMV because of the same maternal
influence. Moreover, congenital CMV in monozygotic twins
has rarely been reported [17]. Monozygotic twins are geneti-
cally identical.
We describe a unique case of congenital CMV in a mono-
zygotic twin gestation, resulting in the intrauterine demise of
one fetus and the survival of the other fetus without compli-
cations. We have followed the survivor for 8 years as of this
writing. This case offers an opportunity to observe a different
course of CMV infection amongst twins.
After a period of secondary infertility, a twin pregnancy was
achieved in a 38-year-old woman using clomiphene therapy.
During the regular prenatal examination, she was shown to have
gestational diabetes mellitus and noted to have the familiar
marker chromosome. Discordant intrauterine growth of the
twins was noted, beginning in the early second trimester, and
a difference in the estimated body weight was also recorded
beginning in the late second trimester using ultrasound exami-
nation. Although the Doppler examination of the umbilical cord
flow and amniotic fluid volumewerewithin normal limits, a fetal
demise was incidentally diagnosed at 36 weeks of gestation
during an ultrasound examination. A low segment cesareancs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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position was extracted. The body weight was 2,560 g, the length
was 43.5 cm, the head circumference was 32.5 cm, and the
Apgar scores were 6 and 8 at 1 and 5 minutes, respectively; the
second female was a macerated stillborn.
On the initial physical examination, the firstborn was found
to be a normal infant. The laboratory data showed nonspecific
IgM (14.9 mg/dL), a normal urinalysis, and a mild thrombo-
cytopenia. There was no clinical evidence of congenital infec-
tion and the general condition was stable. After counseling with
the mother, the fetal demise and placenta were sent for post-
mortem examination. The body weight was 1,780 g, the length
was 46 cm, and the head circumference was 31 cm. The kidneys
(Fig. 1A and B) and lungs (Fig. 1C) had inclusion bodies in
giant cells suggestive of CMV infection. Immunohistochemical
staining for CMV was positive. A single umbilical artery was
present, but no other remarkable congenital anomalies were
observed. Examination of the placenta, both grossly and
microscopically, showed that the fetal membranes were dia-
mniotic and monochorionic (Fig. 1D and E), with the placental
plate of the fetal demise smaller than the liveborn. Two
placental plates with communicating umbilical vascular
branches were found. No inclusion-bearing cells were seen on
microscopic examination; however, villous hypervascularity
and lymphohistiocytic villitis was noted.
We followed the bottle-feeding liveborn serially. At 4 weeks
of age, the serum CMV-IgG titer was 1,741 AU/mL, and the
CMV-IgM index (0.18) was negative. At 2 months of age, the
CMV-IgG was 1,753.8 AU/mL, but the CMV-IgM index (1.00)
was positive. Liver function tests were normal. At 4 months of
age, the CMV-IgG was 1,312.8 AU/mL and the CMV-IgM
index (0.55) was still positive. The urine culture for CMV
was negative, and eye and otologic examinations were also
normal at 2, 4, 8, and 12 months of age. Bilateral, multiple,Fig. 1. (A and B) Multiple cytomegalovirus intranuclear viral inclusions are ill
(H&E stain). Magnification was 200 for (AeC) and 400 for the small windo
(E) Monochorionic dividing membrane of placenta composed of two amnia withosmall cerebral subependymal cysts [22] were demonstrated by
serial brain echograms beginning at 2 weeks of age. The 1-year-
old child showed a normal growth pattern and continues to
undergo clinical follow-up every year. The child received
psychologic assessment and the Chinese Child Developmental
Inventory test was administered at 4 years of age, revealing an
intelligence quotient of 147e170%. The 8-year-old child has no
clinically significant brain deficits or sensorineural hearing loss
as of this writing.
Hematogenous spread appears to be the most likely
pathway of vertical transmission and the placenta is the main
entrance for CMV to the fetuses [23]. It is presumed that
women who transmit CMV to the fetuses might have defective
immunologic responses [24,25]. But some suggested that
placenta might also play an important role in vertical trans-
mission as the protective factor by producing interferon when
challenged [26] or acting as a nonspecific barrier [27].
The factors influencing the severity of CMVare not known,
although maternal and fetal immune status, viral strain viru-
lence [15], and reinfection with different strains [1] are
considered to play a role. Based on maternal and fetal symp-
toms and signs alone, it is often difficult to suspect prenatal
CMV infection. Thus, the present case of a CMV-infected twin
gestation provides an interesting model for discussion because
genetically identical fetuses are simultaneously exposed to the
same maternal influence. However, the perinatal outcome was
quite different.
In this case, it is clear that the smaller fetus was affected
more severely by the intrauterine-acquired CMV infection
than the larger fetus. The combination of growth retardation
and intrauterine viral infection causing an impaired immuno-
logic response might explain the difference in fetal involve-
ment amongst the twins. The absence of an apparent infection
might suggest a more effective fetal immune response in theustrated in the right and left kidneys, respectively and (C) in the lungs in
w. (D) A gross image of the diamniotic, monochorionic placenta is shown.
ut intervening chorion is shown. H&E¼ hematoxylin and eosin.
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maternal immune status are assumed to have been identical in
both twins.
It is generally thought that the placenta is the main portal for
CMV and that placental infection following maternal viremia
is the initiating step in fetal infection [23]. In the present case of
twins with the same placenta, only one twin was severely
infected. Because the placenta was exposed to the virus at that
same time and with the same viral load, both twins would be
infected by transplacental spread of maternal viremia. Thus,
the placenta of the infected twin may have not acted as a barrier
to viral transmission. The placental vascular communication
between the twins contributing to the discordant outcome
cannot be established with certainty. The serologic diagnosis is
complicated by maternal transplacental IgG antibody and the
common occurrence of perinatally acquired disease, making
studies after the first few weeks of life inconclusive in estab-
lishing the diagnosis of congenital CMV.
Our case shows that intrauterine-acquired CMV infections
involving monozygotic twins with the same genotype can
result in totally different outcomes, even if they are simulta-
neously exposed to the same maternal influence. We postulate
that there are not only maternal factors, placental barriers,
viral load or virulence but some other unknown factors
affecting fetuses infected with CMV from maternal infection.
Influences of unknown factors (such as the relationship
between the virus and its environment or the interaction of
maternal and fetal immune systems) on the vertical trans-
mission rate are unclear, and further investigations are needed
to improve our knowledge of congenital CMV infection.References
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